keyword
https://read.qxmd.com/read/38654668/monocyte-response-to-sars-cov-2-protein-orf8-is-associated-with-severe-covid-19-infection-in-patients-with-chronic-lymphocytic-leukemia
#1
JOURNAL ARTICLE
Gordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, Michelle K Manske, Jithma P Abeykoon, Vaishali Bhardwaj, Taylor L Witter, Matthew J Schellenberg, Kari G Rabe, Neil E Kay, Sameer A Parikh, Thomas E Witzig
The open reading frame 8 (ORF8) protein, encoded by the SARS-CoV-2 virus after infection, stimulates monocytes/macrophages to produce pro-inflammatory cytokines. We hypothesized that a positive ex vivo monocyte response to ORF8 protein pre-COVID-19 would be associated with subsequent severe COVID-19. We tested ORF8 ex vivo on peripheral blood mononuclear cells (PBMCs) from 26 anonymous healthy blood donors and measured intracellular cytokine/chemokine levels in monocytes by flow cytometry. The % monocytes staining positive in the sample and change in mean fluorescence intensity (ΔMFI) after ORF8 were used to calculate the adjusted MFI for each cytokine...
April 24, 2024: Haematologica
https://read.qxmd.com/read/38654593/revisiting-the-role-of-measurable-residual-disease-in-flt3-mutated-acute-myelogenous-leukemia
#2
EDITORIAL
Håkon Reikvam, Richard Dillon
No abstract text is available yet for this article.
April 23, 2024: Expert Review of Hematology
https://read.qxmd.com/read/38654085/intelligent-berberine-loaded-erythrocytes-attenuated-inflammatory-cytokine-productions-in-macrophages
#3
JOURNAL ARTICLE
Zahra Sadat Aghili, Mauro Magnani, Mehdi Ghatrehsamani, Azar Nourian Dehkordi, Seyed Abbas Mirzaei, Mehdi Banitalebi Dehkordi
Erythrocytes are impressive tools for drug delivery, especially to macrophages. Therefore, berberine was loaded into erythrocytes using both hypotonic pre-swelling and endocytosis methods to target macrophages. Physicochemical and kinetic parameters of the resulting carrier cells, such as drug loading/release kinetics, osmotic fragility, and hematological indices, were determined. Drug loading was optimized for the study using Taguchi experimental design and lab experiments. Loaded erythrocytes were targeted to macrophages using ZnCl2 and bis-sulfosuccinimidyl-suberate, and targeting was evaluated using flow cytometry and Wright-Giemsa staining...
April 23, 2024: Scientific Reports
https://read.qxmd.com/read/38652054/car-t-therapy-followed-by-hematopoietic-stem-cell-transplantation-can-improve-survival-in-children-relapsed-refractory-philadelphia-chromosome-positive-b-cell-acute-lymphoblastic-leukemia
#4
JOURNAL ARTICLE
Yao Li, Guan-Hua Hu, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Pan Suo, Yu Wang, Yi-Fei Cheng, Xiao-Jun Huang
BACKGROUND: Philadelphia chromosome (Ph)-positive B-cell acute lymphoblastic leukemia (ALL) has a high complete remission (CR) rate, but relapse and prolonged measurable residual disease remain serious problems. We sought to describe the CR rate measurable residual disease negative rate and address the results and safety of pediatric patients who underwent after receiving chimeric antigen receptor (CAR) specific for CD19 (CAR-19) followed by hematopoietic stem cell transplantation (HSCT) for the treatment of Ph-positive ALL...
April 23, 2024: Journal of Pediatric Hematology/oncology
https://read.qxmd.com/read/38651850/mycosis-fungoides-with-large-cell-transformation-cd30-and-b-cell-chronic-lymphocytic-leukemia
#5
JOURNAL ARTICLE
Mikela Petković, Ivana Ilić, Ružica Jurakić Tončić, Ivo Radman-Livaja, Romana Čeović
Mycosis fugnoides (MF) is an indolent cutaneous T-cell lymphoma (CTLC) and is the most common of all cutaneous lymphomas. An increased risk for developing a second primary malignancy in patients with CTCL has been described in several studies, with a range from 1.04 to 2.4 (1-4). Caucasian males are at higher risk for MF development. MF is often diagnosed at ages between 55 and 67 years, and second malignancy usually occurs 5 or 6 years after the diagnosis of MF was established (5). The most common second primary malignancies include non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), lung carcinoma, bladder carcinoma, and melanoma...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38650005/heterodimerization-of-t-cell-engaging-bispecific-antibodies-to-enhance-specificity-against-pancreatic-ductal-adenocarcinoma
#6
JOURNAL ARTICLE
Alan W Long, Hong Xu, Brian H Santich, Hongfen Guo, Sayed Shahabuddin Hoseini, Elisa de Stanchina, Nai-Kong V Cheung
BACKGROUND: EGFR and/or HER2 expression in pancreatic cancers is correlated with poor prognoses. We generated homodimeric (EGFRxEGFR or HER2xHER2) and heterodimeric (EGFRxHER2) T cell-engaging bispecific antibodies (T-BsAbs) to direct polyclonal T cells to these antigens on pancreatic tumors. METHODS: EGFR and HER2 T-BsAbs were constructed using the 2 + 2 IgG-[L]-scFv T-BsAbs format bearing two anti-CD3 scFvs attached to the light chains of an IgG to engage T cells while retaining bivalent binding to tumor antigens with both Fab arms...
April 23, 2024: Journal of Hematology & Oncology
https://read.qxmd.com/read/38647418/therapeutic-efficacy-of-ras-inhibitor-trametinib-using-a-juvenile-myelomonocytic-leukemia-patient-derived-xenograft-model
#7
JOURNAL ARTICLE
Alex Q Lee, Hiroaki Konishi, Masami Ijiri, Yueju Li, Arun Panigrahi, Jeremy Chien, Noriko Satake
Juvenile myelomonocytic leukemia (JMML) is an aggressive pediatric leukemia with few effective treatments and poor outcomes even after stem cell transplantation, the only current curative treatment. We developed a JMML patient-derived xenograft (PDX) mouse model and demonstrated the in vivo therapeutic efficacy and confirmed the target of trametinib, a RAS-RAF-MEK-ERK pathway inhibitor, in this model. A PDX model was created through transplantation of patient JMML cells into mice, up to the second generation, and successful engraftment was confirmed using flow cytometry...
April 22, 2024: Pediatric Hematology and Oncology
https://read.qxmd.com/read/38646638/hypofractionated-radiotherapy-combined-with-lenalidomide-improves-systemic-antitumor-activity-in-mouse-solid-tumor-models
#8
JOURNAL ARTICLE
Kateryna Onyshchenko, Ren Luo, Xi Rao, Xuanwei Zhang, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Niedermann
Background: Hypofractionated radiotherapy (hRT) can induce a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade (ICB). However, clinically, this effect is still rare, and ICB-mediated adverse events are common. Lenalidomide (lena) is an anti-angiogenic and immunomodulatory drug used in the treatment of hematologic malignancies. We here investigated in solid tumor models whether lena can enhance the abscopal effect in double combination with hRT...
2024: Theranostics
https://read.qxmd.com/read/38644993/multi-niche-human-bone-marrow-on-a-chip-for-studying-the-interactions-of-adoptive-car-t-cell-therapies-with-multiple-myeloma
#9
Delta Ghoshal, Ingrid Petersen, Rachel Ringquist, Liana Kramer, Eshant Bhatia, Thomas Hu, Ariane Richard, Reda Park, Jenna Corbin, Savi Agarwal, Abel Thomas, Sebastian Ramirez, Jacob Tharayil, Emma Downey, Frank Ketchum, Abigail Ochal, Neha Sonthi, Sagar Lonial, James N Kochenderfer, Reginald Tran, Mandy Zhu, Wilbur A Lam, Ahmet F Coskun, Krishnendu Roy
UNLABELLED: Multiple myeloma (MM), a cancer of bone marrow plasma cells, is the second-most common hematological malignancy. However, despite immunotherapies like chimeric antigen receptor (CAR)-T cells, relapse is nearly universal. The bone marrow (BM) microenvironment influences how MM cells survive, proliferate, and resist treatment. Yet, it is unclear which BM niches give rise to MM pathophysiology. Here, we present a 3D microvascularized culture system, which models the endosteal and perivascular bone marrow niches, allowing us to study MM-stroma interactions in the BM niche and model responses to therapeutic CAR-T cells...
April 12, 2024: bioRxiv
https://read.qxmd.com/read/38643306/interaction-of-olive-oil-based-propolis-and-caffeic-acid-phenethyl-ester-with-methylprednisolone-used-in-the-treatment-of-human-acute-myeloid-leukemia
#10
JOURNAL ARTICLE
Hamide Dogan, A Ata Ozcimen, Sibel Silici
BACKGROUND: Methylprednisolone (MP) is a pharmaceutical agent employed in the management of Leukemia, which is a systemic malignancy that arises from abnormalities in the hematological system. Numerous investigations in the field of cancer research have directed their attention towards propolis, a natural substance with significant potential as a treatment-supportive agent. Its utilization aims to mitigate the potential adverse effects associated with chemotherapy medications. The objective of this study was to examine the impact of olive oil-based propolis (OEP) and caffeic acid phenethyl ester (CAPE) on the treatment of acute myeloid leukemia, as well as to determine if they exhibit a synergistic effect when combined with the therapeutic support product methylprednisolone...
April 20, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38639201/immunophenotypic-clustering-in-paediatric-acute-myeloid-leukaemia
#11
JOURNAL ARTICLE
Hui Liu, Kefei Wu, Wenting Hu, Xiaoxiao Chen, Yanjing Tang, Yani Ma, Changcheng Chen, Yangyang Xie, Lisha Yu, Jun Huang, Shuhong Shen, Xiang Wang
Acute myeloid leukaemia (AML) is a highly heterogeneous disease, exhibiting diverse subtypes according to the characteristics of tumour cells. The immunophenotype is one of the aspects acquired routinely through flow cytometry in the diagnosis of AML. Here, we characterized the antigen expression in paediatric AML cases across both morphological and molecular genetic subgroups. We discovered a subgroup of patients with unfavourable prognosis that can be immunologically characterized, irrespective of morphological FAB results or genetic aberrations...
April 19, 2024: British Journal of Haematology
https://read.qxmd.com/read/38639167/stat5-phosphorylation-plus-minimal-residual-disease-defines-a-novel-risk-classification-in-adult-b-cell-acute-lymphoblastic-leukaemia
#12
JOURNAL ARTICLE
Xiuli Xu, Zicong Huang, Chenhao Ding, Shiyu Deng, Jiawang Ou, Zihong Cai, Yang Zhou, Haimei Liang, Junjie Chen, ZhiXiang Wang, Xiaoli Liu, Li Xuan, Qifa Liu, Zhongxin Zheng, Zhen Li, Hongsheng Zhou
The dysregulation of the Janus family tyrosine kinase-signal transducer and activator of transcription (JAK-STAT) is closely related to acute lymphoblastic leukaemia (ALL), whereas the clinical value of phosphorylated STAT5 (pSTAT5) remains elusive. Herein we performed a prospective study on clinical significance of flow cytometry-based pSTAT5 in adult B-ALL patients. A total of 184 patients were enrolled in the Precision-Classification-Directed-Target-Total-Therapy (PDT)-ALL-2016 cohort between January 2018 and December 2021, and STAT5 phosphorylation was detected by flow cytometry at diagnosis...
April 19, 2024: British Journal of Haematology
https://read.qxmd.com/read/38637142/safety-and-efficacy-of-para-aminohippurate-coinfusion-for-renal-protection-during-peptide-receptor-radiotherapy-in-patients-with-neuroendocrine-tumors
#13
JOURNAL ARTICLE
Alexandros Moraitis, Walter Jentzen, Pedro Fragoso Costa, David Kersting, Stephan Himmen, Marta Coelho, Marian Meckel, Cees J A van Echteld, Wolfgang P Fendler, Ken Herrmann, Miriam Sraieb
Para -aminohippurate, also known as p -aminohippuric acid (PAH), is used clinically to measure effective renal plasma flow. Preclinically, it was shown to reduce 177 Lu-DOTATOC uptake in the kidneys while improving bioavailability compared with amino acid (AA) coinfusion. We report the safety and efficacy of PAH coinfusion during peptide receptor radiotherapy in patients with neuroendocrine tumors. Methods: Twelve patients with metastatic or unresectable gastroenteropancreatic neuroendocrine tumors received 177 Lu-DOTATOC in 33 treatment cycles...
April 18, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38636244/factors-affecting-in-hospital-mortality-in-patients-with-miliary-tuberculosis-a-retrospective-cohort-study
#14
JOURNAL ARTICLE
Jumpei Taniguchi, Shotaro Aso, Taisuke Jo, Hiroki Matsui, Kiyohide Fushimi, Hideo Yasunaga
BACKGROUND: Miliary tuberculosis (TB) is a fatal disease; thus, prompt diagnosis and immediate intervention are indispensable. However, the risk factors for in-hospital mortality in patients with miliary TB remain unclear. Therefore, this study aimed to identify the factors associated with in-hospital mortality in patients with miliary TB using a Japanese nationwide inpatient database. METHODS: Patients diagnosed with miliary TB between July 2010 and March 2022 were enrolled from the Diagnosis Procedure Combination database...
April 17, 2024: Respiratory Investigation
https://read.qxmd.com/read/38634996/an-unfavorable-and-a-successful-pregnancy-outcome-during-and-after-treatment-of-gamma-heavy-chain-disease
#15
JOURNAL ARTICLE
Masataka Hosoi, Kazunori Ueno, Jun Kikuchi, Jun Miyauchi, Reina Ooka, Kaito Takikawa, Yuya Arai, Misato Kikuchi, Takuro Watanabe
Gamma heavy chain disease (gHCD) is a rare B-cell lymphoproliferative disorder that mostly occurs after childbearing age. Here we report the first case of gHCD in a pregnant patient that was diagnosed in the second trimester, and another pregnancy in the same patient after initial treatment for gHCD. The former pregnancy ended in intrauterine fetal death, believed to be caused by insufficient maternal blood flow due to multiple placental infarcts. The latter pregnancy course was uneventful. Although we cannot rule out the possibility that the poor outcome of the former pregnancy was due to an unfortunate complication independent of gHCD, the courses of these pregnancies suggest that non-lymphomatous gamma heavy chain may have a significant impact on pregnancy and that its removal by treatment may improve outcomes...
April 18, 2024: International Journal of Hematology
https://read.qxmd.com/read/38632623/a-tempo-spatial-controllable-microfluidic-shear-stress-generator-for-in-vitro-mimicking-of-the-thrombus
#16
JOURNAL ARTICLE
Zhihang Yu, Yiqun Chen, Jingjing Li, Chang Chen, Huaxiu Lu, Siyuan Chen, Tingting Zhang, Tianruo Guo, Yonggang Zhu, Jing Jin, Sheng Yan, Huaying Chen
Pathological conditions linked to shear stress have been identified in hematological diseases, cardiovascular diseases, and cancer. These conditions often exhibit significantly elevated shear stress levels, surpassing 1000 dyn/cm2 in severely stenotic arteries. Heightened shear stress can induce mechanical harm to endothelial cells, potentially leading to bleeding and fatal consequences. However, current technology still grapples with limitations, including inadequate flexibility in simulating bodily shear stress environments, limited range of shear stress generation, and spatial and temporal adaptability...
April 17, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38630021/the-efficacy-of-tranexamic-acid-in-reducing-perioperative-drainage-in-cardiac-surgery-with-cardiopulmonary-bypass
#17
JOURNAL ARTICLE
Murat Ziya Bağiş, Bişar Amaç
INTRODUCTION: Although cardiopulmonary bypass procedures remain a critical treatment option for heart disease, they come with risks, including hemorrhage. Tranexamic acid is known to reduce morbidity and mortality in surgical hemorrhage. OBJECTIVE: This study aimed to evaluate the efficacy of tranexamic acid, which is routinely used to treat hemorrhage, in decreasing the amount of intraoperative and postoperative drainage. METHOD: A total of 80 patients who underwent cardiac surgery with cardiopulmonary bypass were included in this retrospective study...
April 17, 2024: Brazilian Journal of Cardiovascular Surgery
https://read.qxmd.com/read/38625506/bernard-soulier-syndrome-caused-by-a-novel-gp1bb-variant-and-22q11-2-deletion
#18
JOURNAL ARTICLE
Rintaro Nagoshi, Atsushi Sakamoto, Tsuyoshi Imai, Toru Uchiyama, Tadashi Kaname, Shinji Kunishima, Akira Ishiguro
Bernard-Soulier syndrome (BSS) is caused by defects in GP1BA, GP1BB, or GP9 genes. Patients with 22q11.2 deletion syndrome (22q11.2DS) are obligate carriers of BSS because GP1BB resides on chromosome 22q11.2. A 15-month-old girl without bleeding symptoms had giant platelets and thrombocytopenia. Physical findings and macrothrombocytopenia suggested 22q11.2DS, which was confirmed by fluorescence in situ hybridization. Flow cytometry showed decreased GPIbα on the platelets. Gene panel testing revealed a novel variant in GP1BB, p...
April 16, 2024: International Journal of Hematology
https://read.qxmd.com/read/38625415/abnormal-frequency-of-the-memory-b-cell-subsets-and-plasmablasts-in-patients-with-congenital-severe-hemophilia-a-correlation-with-inhibitor-formation
#19
JOURNAL ARTICLE
Omid Reza Zekavat, Yasaman Movahednezhad, Amin Shahsavani, Sezaneh Haghpanah, Negin Shokrgozar, Hossein Golmoghaddam, Mehdi Kalani, Mohammad Reza Bordbar, Nargess Arandi
BACKGROUND: Development of antibodies against infused Factor VIII (FVIII) or "inhibitors" represents a major challenge following FVIII replacement therapy in patients with hemophilia A (HA). Recent studies have shown that certain cellular compartments of the immune system contribute to the production of such antibodies. Herein, we determined the frequency of class-switched CD19+ IgD- CD27+ /non-class-switched CD19+ IgD+ CD27+ memory B cell subsets and CD19+ CD27hi CD38hi plasmablasts in patients with severe HA and their association with the development of inhibitors in these patients...
April 16, 2024: Blood Research
https://read.qxmd.com/read/38623681/a-case-of-blastic-plasmacytoid-dendritic-cell-neoplasm-with-orbital-tumor-as-the-initial-symptom
#20
Peizhang Li, Naiqi Pang, Meiqin Li, Juan Xie, Ying Wang
BACKGROUND: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy arising from precursor dendritic cells. It is a rare and challenging clinical presentation. For decades, there has been no treatment course for managing BPDCN and its overall prognosis is poor. METHODS AND RESULTS: We report a 27-year-old man who was admitted to the hospital due to an orbital tumor as the first symptom. Progressive enlargement of the orbital tumor was accompanied by multiple purple circular nodules on the body trunk...
April 1, 2024: Clinical Laboratory
keyword
keyword
96701
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.